Abstract:The kidney, an essential excretory organ of the body, performs a series of crucial physiological functions such as waste removal, maintenance of electrolyte and acid–base balance, and endocrine regulation. Due to its rich blood flow and high metabolic activity, the kidney is susceptible to damage. Currently, kidney injury is classified into acute kidney injury (AKI) and chronic kidney disease (CKD), both of which are associated with high rates of morbidity and mortality on a global scale. The current clinical diagnosis of renal injury relies on the assessment of renal filtration function using creatinine and urea nitrogen as "gold-standard" markers. However, the delayed response time, limited specificity, and reduced accuracy of creatinine and urea nitrogen in evaluating kidney injury have significantly hindered advancements in diagnostic methods for kidney injury. Urinary protein is widely utilized as a biomarker for the early diagnosis of kidney injury due to the selectivity of the glomerular filtration system determining whether proteins can pass through the filtration barrier based on their size and charge. Therefore, as a complex biological sample with varying charges and particle sizes, urinary protein is considered an ideal indicator for monitoring the progression of kidney disease. Exploring the relationship between urinary protein and the advancement of kidney injury based on differences in particle size and charge offers a new perspective for assessing and treating such injuries. Hence, we conducted a comprehensive review of 74 relevant studies to gain a thorough understanding of the physiological mechanism and significance of proteinuria production. The aim was to explore the challenges and opportunities in clinical urine protein detection, as well as to discuss strategies targeting glomerular filtration barriers in order to effectively reduce urine protein levels and treat kidney injury, which could provide a new perspective for identifying the progression of kidney injury.

The research status and prospect of Periostin in chronic kidney disease

Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells

Predicting Cardiovascular Mortality in Chronic Kidney Disease (CKD) Patients.

Advances in the Progression and Prognosis Biomarkers of Chronic Kidney Disease

Research progress of periostin and osteoporosis

Biomarkers for Early Diagnosis of Acute Kidney Injury: Current Progress and Clinical prospects.

Interference of periostin attenuates pathological changes, proinflammatory markers and renal fibrosis in diabetic kidney injury

Pathogenesis and treatment progress in chronic kidney disease after acute kidney injury

Unraveling the Pathophysiological Mechanisms of the Progression from Acute Kidney Injury to Acute Kidney Disease to Chronic Kidney Disease

Periostin in Chronic Liver Diseases: Current Research and Future Perspectives

Podocyte‐related Proteins in Membranous Nephropathy Progression

Recent research progress on the role of ulinastatin in chronic kidney disease

Current and Novel Biomarkers of Progression Risk in Children with Chronic Kidney Disease

Role of Periostin and Nuclear Factor-κB Interplay in the Development of Diabetic Nephropathy

Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression

The role of perirenal adipose tissue deposition in chronic kidney disease progression: Mechanisms and therapeutic implications

Pathophysiology and Therapeutic Targets

The Protective Function of Αklotho in Chronic Kidney Disease: Evidence and Therapeutic Implications

Novel Biomarkers for Kidney Disease: New Frontiers in Early Diagnosis and Monitoring

Chronic Kidney Disease Progression-A Challenge

A Focus on Urine Protein